Compare Fulford India with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DISHMAN PHARMA - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DISHMAN PHARMA FULFORD INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 398.8 25.1 1,589.4% View Chart
P/BV x 6.2 3.3 185.7% View Chart
Dividend Yield % 0.1 0.7 12.7%  

Financials

 FULFORD INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DISHMAN PHARMA
Mar-16
FULFORD INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs942374 251.6%   
Low Rs450129 349.1%   
Sales per share (Unadj.) Rs691.4197.8 349.5%  
Earnings per share (Unadj.) Rs11.521.2 54.0%  
Cash flow per share (Unadj.) Rs15.434.7 44.2%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.8 36.2%  
Book value per share (Unadj.) Rs380.0179.9 211.2%  
Shares outstanding (eoy) m3.9080.69 4.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 79.1%   
Avg P/E ratio x60.711.9 511.7%  
P/CF ratio (eoy) x45.37.2 625.2%  
Price / Book Value ratio x1.81.4 130.9%  
Dividend payout %17.49.4 185.0%   
Avg Mkt Cap Rs m2,71420,306 13.4%   
No. of employees `0000.40.8 53.6%   
Total wages/salary Rs m5055,355 9.4%   
Avg. sales/employee Rs Th6,073.019,252.7 31.5%   
Avg. wages/employee Rs Th1,137.46,459.5 17.6%   
Avg. net profit/employee Rs Th100.72,064.1 4.9%   
INCOME DATA
Net Sales Rs m2,69615,961 16.9%  
Other income Rs m125265 47.2%   
Total revenues Rs m2,82216,226 17.4%   
Gross profit Rs m-464,103 -1.1%  
Depreciation Rs m151,091 1.4%   
Interest Rs m10944 1.0%   
Profit before tax Rs m542,334 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10624 1.5%   
Profit after tax Rs m451,711 2.6%  
Gross profit margin %-1.725.7 -6.7%  
Effective tax rate %17.726.7 66.2%   
Net profit margin %1.710.7 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,73811,018 15.8%   
Current liabilities Rs m5459,517 5.7%   
Net working cap to sales %44.39.4 470.7%  
Current ratio x3.21.2 275.7%  
Inventory Days Days48110 43.9%  
Debtors Days Days435 12.4%  
Net fixed assets Rs m1216,304 0.1%   
Share capital Rs m39161 24.2%   
"Free" reserves Rs m1,44312,907 11.2%   
Net worth Rs m1,48214,516 10.2%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m2,07729,805 7.0%  
Interest coverage x6.73.5 193.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.5 242.5%   
Return on assets %2.68.9 29.3%  
Return on equity %3.011.8 25.6%  
Return on capital %4.317.5 24.6%  
Exports to sales %024.8 0.0%   
Imports to sales %24.53.7 654.4%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m659596 110.6%   
Fx inflow Rs m174,952 0.3%   
Fx outflow Rs m673697 96.6%   
Net fx Rs m-6564,255 -15.4%   
CASH FLOW
From Operations Rs m902,786 3.2%  
From Investments Rs m105-1,529 -6.8%  
From Financial Activity Rs m-14-941 1.5%  
Net Cashflow Rs m181316 57.0%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 3.7 102.7%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 22.1 95.9%  
Shareholders   4,783 46,261 10.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   FDC  ALEMBIC  DR. REDDYS LAB  AJANTA PHARMA  SUVEN LIFE SCIENCES  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 296 Points Higher; Coal India, UPL & Hindalco Surge Over 6%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS